Clinical Roundup Immunotherapy before and after lung cancer surgery reduces death risk, disease recurrence September 13, 2024Vol.50 No.34
Clinical Roundup Dysfunctional white blood cells linked to heightened melanoma risk September 13, 2024Vol.50 No.34
Clinical Roundup ImmunityBio announces positive phase II data for Anktiva + checkpoint inhibitors in lung cancer, opens phase III trial September 13, 2024Vol.50 No.34
Clinical Roundup Interim results of phase II study shows survival benefit of THIO in NSCLC September 13, 2024Vol.50 No.34
Clinical Roundup Research shows applications of novel cfDNA approach in precision medicine September 13, 2024Vol.50 No.34
Clinical Roundup Dexamethasone reduces infusion-related reactions in patients with EGFR-mutated NSCLC treated with intravenous Rybrevant September 13, 2024Vol.50 No.34
Clinical Roundup Mechanisms that clear mutations drive field cancerization in mammary tissue September 13, 2024Vol.50 No.34
Clinical Roundup New AI model can prevent unnecessary prostate removals September 13, 2024Vol.50 No.34
Clinical Roundup T-DXd shows promising results in treating HER2+ metastatic colorectal cancer September 13, 2024Vol.50 No.34
Clinical Roundup Immunological features predict treatment response for advanced solid tumors September 13, 2024Vol.50 No.34
